Index
Module 6 • Infectious Diseases
Infectious Diseases I
54%
Data Tables
Infectious Diseases I
Jacob Schwarz ~2 min read Module 6 of 20
33
/ 61

Infectious Diseases I

Clinical

Definition

ACG 2013

IDSA/SHEA 2018

IDSA/SHEA

2021 Focused Update

ACG 2021

Second

recurrence

Vancomycin

PO, then

28-day dosage

taper

Vancomycin in

tapered and pulsed

regimen

β€”ORβ€”

Vancomycin 125 mg

PO 4 times daily

for 10 days, then

rifaximin 400 mg

TID for 20 days

β€”ORβ€”

Fidaxomicin 200 mg

PO/NG/FT BID for

10 days β€”ORβ€”

Fecal microbiota

transplantation

Fidaxomicin 200 mg PO/

NG/FT BID for 10 daysβ€”

ORβ€”BID for 5 days, then

once every other day for

20 days

β€”ORβ€”

Vancomycin PO in

tapered and pulsed

regimen

β€”ORβ€”

Vancomycin 125 mg 4

times daily PO for 10

days, then rifaximin 400

mg TID for 20 days

β€”ORβ€”

Fecal microbiota

transplantation (preferably

after 3 antibiotic courses

are attempted and

completed)

Adjunctive therapy:

Bezlotoxumab 10 mg/

kg IV once during

administration of above

antibiotics

Recommend

fecal microbiota

transplant (FMT)

to prevent further

recurrences (strong

recommendation,

moderate-quality

evidence)

Suggest bezlotoxumab

for high risk of

recurrence (conditional

recommendation,

moderate-quality

evidence)

ACG = American College of Gastroenterology; BID = twice daily; FT = feeding tube; IDSA = Infectious Diseases Society of America; IV = intravenously; NS = normal

saline; PO = orally; SHEA = Society for Healthcare Epidemiology of America; TID = 3 times daily.

Information from: Johnson S, Lavergne V, Skinner AM, et al. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for

Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Inf Dis 2021. Available

at www.idsociety.org/globalassets/idsa/practice-guidelines/cdi-2021-focused-update.pdf. McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for

Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of

America (SHEA). Clin Infect Dis 2018;66:987-94. Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium

difficile Infections. Am J Gastroenterol 2013;108:478–98.; Kelly CR, Fischer M, Allegretti JP, et al. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of
Clostridioides difficile Infections, Am J Gastroenterol 2021; 116: 1124-1147.
Table 3. Treatment Options for Clostridioides difficile Infection (continued)
HD Video Explanation β€” Synchronized with PDF
Starts at: minute 32 Open on YouTube